Amneal Pharmaceuticals, Inc. Class A Common Stock Free Cash Flow Generation Index
Amneal Pharmaceuticals, Inc. Class A Common Stock free cash flow generation index. Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Free Cash Flow Generation Index of 0.61x as of September 2026. Free cash flow of $60.70 Million represents 1% of operating cash flow ($100.28 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Free cash flow generation index of Amneal Pharmaceuticals, Inc. Class A Common Stock from 2014 to 2025. Historical FCF Generation Index trend for Amneal Pharmaceuticals, Inc. Class A Common Stock across 12 annual periods. See Amneal Pharmaceuticals, Inc. Class A Com financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Amneal Pharmaceuticals, Inc. Class A Common Stock Free Cash Flow Generation Index by Year (2014–2025)
Amneal Pharmaceuticals, Inc. Class A Common Stock free cash flow generation index by year from 2014 to 2025. Year-by-year Free Cash Flow Generation Index for Amneal Pharmaceuticals, Inc. Class A Common Stock. For the full cash flow conversion analysis, see AMRX operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.79x | $269.93 Million | $339.99 Million | $70.06 Million | ▲ +6.4% |
| 2024 | 0.75x | $220.11 Million | $295.10 Million | $74.99 Million | ▼ -6.7% |
| 2023 | 0.80x | $276.39 Million | $345.58 Million | $69.19 Million | ▲ +304.2% |
| 2022 | -0.39x | $-25.50 Million | $65.10 Million | $90.59 Million | ▼ -148.8% |
| 2021 | 0.80x | $194.09 Million | $241.82 Million | $47.73 Million | ▼ -4.1% |
| 2020 | 0.84x | $317.16 Million | $379.00 Million | $61.84 Million | ▲ +101.5% |
| 2019 | -56.14x | $-95.73 Million | $1.71 Million | $97.43 Million | ▼ -9273.8% |
| 2018 | 0.61x | $153.14 Million | $250.23 Million | $97.09 Million | ▲ +19.5% |
| 2017 | 0.51x | $119.92 Million | $234.19 Million | $114.27 Million | ▲ +717.2% |
| 2016 | -0.08x | $-9.55 Million | $115.06 Million | $124.61 Million | ▲ +30.4% |
| 2015 | -0.12x | $-12.50 Million | $104.88 Million | $117.38 Million | ▼ -140.7% |
| 2014 | 0.29x | $32.87 Million | $112.26 Million | $79.38 Million | — |